LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Maximus, Inc. (“Maximus” or the “Company”) (NYSE: MMS) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Maximus page on our website at www.glancylaw.com/case/maximus-inc.
On February 4, 2016, Maximus shocked investors with an earnings announcement that disclosed poor first quarter 2016 financial results, again missing expectations and confirming its inability to meet Health Assessment Advisory Service (“HAAS”) contract assessment targets. The reduced earnings were based in part on weak performance of the HAAS contract, which “tempered operating margin.”
On this news, the Company’s share price fell substantially over two trading sessions, thereby injuring investors.
If you purchased Maximus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.